KidneyCAN

Our mission is to accelerate cures for kidney cancer. We engage in patient advocacy and power research by supporting government and industry research funding, facilitating research collaborations, and offering direct financial support for clinical and laboratory researchers with promising ideas. Together, we can find the cure.

Latest from KidneyCAN

What Patients With Kidney Cancer Need to Know About Radiation Therapy

March 29, 2024

Article

An expert explains what patients need to keep in mind and what conversations they should be having with their care teams.

Research Continues for Best Immunotherapy Order in Advanced RCC

July 21, 2023

Article

Even with the increase of immunotherapy utilization to treat patients with advanced renal cell carcinoma, more research is needed to determine in which order to administer it as later lines of therapy.

In Kidney Cancer Treatment, ‘Personalized Biomarkers Work’

July 20, 2023

Video

Therapies that target specific characteristics on kidney cancer cells are showing promise in the space, an expert explained.

‘It’s a Time of Hope’ for Kidney Cancer

July 19, 2023

Video

With new treatments being explored, it’s an exciting time for patients with kidney cancer, an expert explained.

How Cancer Teams Leverage Biology in Guiding First-Line Therapy for Clear Cell RCC

July 19, 2023

Article

An expert explained what aspects of a patient’s disease cancer care teams use to determine the best treatment options for patients with clear cell renal cell carcinoma.

BAP1-Mutated RCC Responds to Treatment with Lynparza

July 18, 2023

Article

Patients with BAP1-mutated renal cell carcinoma who were treated with Lynparza obtained responses with favorable side effect profiles.